首页> Journal of clinical oncology : official journal of the American Society of Clinical Oncology> Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A).

Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A).

导出 OA

翻译打印收藏纠错

第一作者： Michael B,Atkins

第一单位： Georgetown Lombardi Comprehensive Cancer Center, Washington, DC.

作者： Michael B,Atkins ^[1] ; Opeyemi A,Jegede ^[2] ; Naomi B,Haas ^[3] ; David F,McDermott ^[4] ; Mehmet A,Bilen ^[5] ; Mark,Stein ^[6] ; Jeffrey A,Sosman ^[7] ; Robert,Alter ^[8] ; Elizabeth R,Plimack ^[9] ; Moshe,Ornstein ^[10] ; Michael,Hurwitz ^[11] ; David J,Peace ^[12] ; Sabina,Signoretti ^[13] ; Thomas,Denize ^[13] ; Alessia,Cimadamore ^[13] ; Catherine J,Wu ^[2] ; David,Braun ^[11] ; David,Einstein ^[4] ; Paul J,Catalano ^[2] ; Hans,Hammers ^[14]

作者单位： Georgetown Lombardi Comprehensive Cancer Center, Washington, DC. ^[1] Dana Farber Cancer Institute, Boston. MA. ^[2] Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA. ^[3] Beth Israel Deaconess Medical Center, Boston, MA. ^[4] Winship Cancer Institute of Emory University, Atlanta, GA. ^[5] Columbia University Weinberg Cancer Center, New York, NY. ^[6] Northwestern University, Chicago, IL. ^[7] Hackensack University Medical Center, Hackensack, NJ. ^[8] Fox Chase Cancer Center, Philadelphia, PA. ^[9] Cleveland Clinic, Cleveland, OH. ^[10] Yale University Cancer Center, New Haven, CT. ^[11] University of Illinois Chicago, Chicago, IL. ^[12] Brigham and Women's Hospital, Boston, MA. ^[13] University of Texas Southwestern Sammons Cancer Center, Dallas, TX. ^[14]

医学主题词抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 肾细胞(Carcinoma, Renal Cell);人类(Humans)

DOI 10.1200/JCO.21.02938

PMID 35442713

发布时间 2024-09-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交